Skip to main content
Clinical Trials/ACTRN12612000410853
ACTRN12612000410853
Recruiting
未知

Response of Patients with Chronic Obstructive Pulmonary Disease to Airvo, as Measured by Carbon Dioxide Levels

Richard Beasley0 sites18 target enrollmentApril 12, 2012

Overview

Phase
未知
Intervention
Not specified
Conditions
Chronic Obstructive Pulmonary Disease
Sponsor
Richard Beasley
Enrollment
18
Status
Recruiting
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
April 12, 2012
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Richard Beasley

Eligibility Criteria

Inclusion Criteria

  • Diagnosis of chronic obstructive pulmonary disease with baseline oxygen saturations of 85\-92%. A raise in transcutaneous carbon dioxide of greater than or equal to 4mmHg on eligibility testing (50% oxygen administration via a mask until transcutaneous carbon dioxide increases by greater than or equal to 4mmHg or for 20 minutes).

Exclusion Criteria

  • An intercurrent chest infection
  • FEV1\>50% predicted
  • FEV1:FVC \>0\.7
  • Baseline transcutaneous carbon dioxide of greater than 60mmHg
  • Diagnosis of a disease causing restriction to chest wall expansion (neuromuscular disease or chest wall dysfunction)
  • Obesity (body mass index greater than or equal to 40\)
  • Inability to tolerate the Airvo device at 25 and 45 Litres per minute
  • Any other condition which, at the investigator's discretion, is believed may present a safety risk or impact the feasibility of the study or the study results.

Outcomes

Primary Outcomes

Not specified

Similar Trials